Head-to-head · Value Score
CoreAge Rx vs Royal Medical Center
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Royal Medical Center a 45. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameRoyal Medical Center
#389 · Grade C · Watch List
Est. first month
From $450/mo (2.5 mg dose, compounded)
Save ~67% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 45 — an est. $149/mo first month, with no teaser step-up baked in. Royal Medical Center isn't out of it: Shoppers who want credentialed MD founder with itemized dose-strength pricing.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Royal Medical Center |
|---|---|---|
| Value Score | 93 (A+) | 45 (C) |
| Est. first month | $149/mo | From $450/mo (2.5 mg dose, compounded) |
| Save vs brand-name | ~89% | ~67% |
| Semaglutide | $149/mo | Not disclosed |
| Tirzepatide | $349/mo | From $450/mo (2.5 mg dose, compounded) |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Royal Medical Center
Royal Medical Center is a physician-led nationwide telehealth practice centered on hormone therapy that also offers a compounded tirzepatide weight-loss program (no semaglutide).
Why it's a deal
- Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
- Tirzepatide pricing fully itemized by dose tier ($450 / $650 / $800 / $1,100) — more transparent than 'starting at' floors
- All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
- Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
- Florida physician with 30+ years of practice — a strong physician-led care signal
The fine print
- Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
- Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
- No LegitScript badge displayed
- States served not enumerated — site says 'nationwide' with no state list
- Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives board, and the same list for the other side is on alternatives to Royal Medical Center.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.